SQuEEZ® Heart Function Analysis Software

About CardioWise

CardioWise is a private, commercial-stage digital health company founded in 2013, specializing in AI-driven cardiac image analysis. Its flagship product, SQuEEZ® (Stretch Quantifier for Endocardial Engraved Zones), has received FDA 510(k) clearance and provides a comprehensive 3D strain analysis of the heart from standard CT scans. The company targets the global cardiology market with a platform designed to increase diagnostic accuracy, enable timely interventions, and reduce healthcare costs, positioning itself at the intersection of cardiovascular diagnostics and AI/machine learning.

Therapeutic Areas